These disclosures are from 13Ds filed with the Securities and Exchange Commission. 13Ds are filed within 10 days of an entity's attaining more than 5% in any class of a company's securities. Subsequent changes in holdings or intentions must be reported in amended filings. This material is from Oct. 10 through Oct. 16, 2024. Source: VerityData

Original Filings

TriMas Trend International Holding disclosed a new position in the packaging, aerospace, and specialty-products company of 4,170,667 shares. Trend International reported that it purchased 3,248,819 of those shares from Aug. 21 through Oct. 15 at prices ranging from $23.83 to $28.02 each. Following the latest purchases, Trend International now owns 10.3% of TriMas' outstanding stock. Shares of TriMas have gained roughly 10% year to date.

Decreases in Holdings

Soleno Therapeutics Carlyle Group decreased its stake in the biopharmaceutical company to 2,468,099 shares. Carlyle Group reported that it sold 1,632,876 Soleno Therapeutics shares from Oct. 7 to Oct. 11 at prices ranging from $48.03 to $58.10 apiece. Following the latest sales, Carlyle Group continues to own 6.2% of Soleno Therapeutics' outstanding stock. Shares of Soleno Therapeutics have gained more than 30% year to date.

ACM Research Shanghai Science and Technology Venture Capital lowered its stake in the chip-equipment company to 5,697,238 shares. Shanghai Science did so through the sale of 1,100,000 ACM Research shares from Oct. 1 through Oct. 8 at prices ranging from $20 to $26.02 each. Following the latest purchases, Shanghai Science continues to own 9.9% of ACM Research's outstanding stock. Shares of ACM Research have slipped about 2% so far in this year.

Diversified Health Trust D.E. Shaw reduced its stake in the healthcare facilities real estate investment trust to 11,994,400 shares. D.E. Shaw did so through the sale of 670,221 Diversified Health Trust shares from Aug. 12 through Oct. 9 at prices ranging from $3 to $4.22 each. Following the latest sales, D.E. Shaw continues to own 4.99% of Diversified Health's outstanding stock, which places it below the 5% threshold that would require it to report further Diversified Health sales. Shares of Diversified Health are about flat so far this year.

Ring Energy Warburg Pincus cut its stake in the independent oil-and-gas-exploration company to 35,520,643 shares. Warburg Pincus reported that it sold 4,400,000 Ring Energy shares on Oct. 8 at a price of $1.62 per share. Warburg Pincus now continues to own 17.9% of Ring's outstanding stock. Shares of Ring have gained about 7% in the year to date.

Dave Section 32 Fund 1, known as Fund 1, lowered its stake in the financial-services company to 1,028,232 shares. Fund 1 did so through the open-market sale of one million Dave shares on Oct. 9 at a price of $40.60 per share. Following the latest sales, Fund 1 continues to own 9.2% of Dave's outstanding stock. Shares of Dave have rocketed over 400% so far in 2024. The company went public in January 2022 through an acquisition by a special-purpose acquisition company.

Email: editors@barrons.com

This content was created by Barron's, which is operated by Dow Jones & Co. Barron's is published independently from Dow Jones Newswires and The Wall Street Journal.

(END) Dow Jones Newswires

October 18, 2024 18:41 ET (22:41 GMT)

Copyright (c) 2024 Dow Jones & Company, Inc.